Viemed Healthcare Inc Revenue Growth Rates (VMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Viemed Healthcare Inc   (NASDAQ: VMD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

VMD's Revenue Growth by Quarter and Year

Viemed Healthcare Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/VMD/growth
https://api.csimarket.com/api/v1/companies/VMD/fundamentals
https://api.csimarket.com/api/v1/companies/VMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
VMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 80.67
2nd Quarter June 78.10
1st Quarter March 75.41
FY 234.18

VMDs Annual Revenue
Viemed Healthcare Inc 's Revenue in the fiscal year 2025 $ 270.28 millions
Viemed Healthcare Inc 's Revenue in the fiscal year 2024 $ 224.26 millions
Viemed Healthcare Inc 's Revenue in the fiscal year 2023 $ 183.01 millions
Viemed Healthcare Inc 's Revenue in the fiscal year 2022 $ 138.83 millions
Viemed Healthcare Inc 's Revenue in the fiscal year 2021 $ 117.06 millions




VMD Revenue third quarter 2026 Y/Y Growth Comment
Viemed Healthcare Inc reported Revenue increase of 12.19% year on year in the third quarter 2026, to $ 80.67 millions, this is lower than Viemed Healthcare Inc 's recent average Revenue improvement of 23.46%.

Looking into third quarter 2026 results within Healthcare Facilities industry 23 other companies have achieved higher Revenue growth. While Viemed Healthcare Inc ' s Revenue growth of 12.19% ranks overall at the positon no. 2246 in the third quarter 2026.


VMD Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.19 %
2nd Quarter June 23.85 %
1st Quarter March 27.53 %
FY   -

Financial Statements
Viemed Healthcare Inc 's third quarter 2026 Revenue $ 80.67 millions VMD's Income Statement
Viemed Healthcare Inc 's third quarter 2025 Revenue $ 71.91 millions Quarterly VMD's Income Statement


VMD Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.29 %
2nd Quarter June 3.57 %
1st Quarter March -1.01 %
FY (Year on Year)   -


Back to VMD Growth rate Comparisons >> Back to VMD Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #24
Healthcare Sector #328
Overall #2246

Revenue Y/Y Growth Statistics
High Average Low
57.42 % 23.46 % -11.05 %
(Dec 31 2020)   (Mar 31 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #24
Healthcare Sector #328
Overall #2246
Revenue Y/Y Growth Statistics
High Average Low
57.42 % 23.46 % -11.05 %
(Dec 31 2020)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Viemed Healthcare Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
80.01 % 6.19 % -21.95 %
(Jun 30 2020)  


VMD's III. Quarter Q/Q Revenue Comment
Viemed Healthcare Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.29% quarter on quarter, to $ 80.67 millions.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Viemed Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1296.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #185
Overall #1296
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #185
Overall #1296
Revenue Q/Q Growth Statistics
High Average Low
80.01 % 6.19 % -21.95 %
(Jun 30 2020)  


VMD's III. Quarter Q/Q Revenue Comment
Viemed Healthcare Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.29% quarter on quarter, to $ 80.67 millions.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Viemed Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1296.


Viemed Healthcare Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 301.61
Y / Y Revenue Growth (TTM) 25.21 %
Year on Year Revenue Growth Overall Ranking # 1000
Seqeuential Revenue Change (TTM) 5.25 %
Seq. Revenue Growth (TTM) Overall Ranking # 2250


Cumulative Revenue growth Comment
Viemed Healthcare Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 25.21% year on year, to $ 302 millions if the fiscal year would have ended in Jun 30 2026.
Viemed Healthcare Inc 's trailing twelve months Revenue growth was higher than company's average 23.73% and higher than 23.1% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 5.25 % from $286.57 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at23.73%.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 171 to 1000.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 24
Healthcare Sector # 193
Overall # 1000

Revenue TTM Y/Y Growth Statistics
High Average Low
63.61 %
 23.73 %
-11.05 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 328
S&P 500 # 2250
Cumulative Revenue growth Comment
Viemed Healthcare Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 25.21% year on year, to $ 302 millions if the fiscal year would have ended in Jun 30 2026.
Viemed Healthcare Inc 's trailing twelve months Revenue growth was higher than company's average 23.73% and higher than 23.1% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 5.25 % from $286.57 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at23.73%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 5.25 % increase from $286.57 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 171 to 1000.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 24
Healthcare Sector # 193
Overall # 1000

Revenue TTM Y/Y Growth Statistics
High Average Low
63.61 %
23.73 %
-11.05 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 328
S&P 500 # 2250




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VMD's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Harvard Apparatus Regenerative Technology Inc 17.89%$ 17.886 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
American Shared Hospital Services15.76%$ 15.761 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions


About Viemed Healthcare Inc Revenue Growth Rates (VMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Viemed Healthcare Inc (CIK 1729149).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001729149-26-000056
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Viemed Healthcare Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.